Tridek-One secure 3 million euros from two major biotech investors
Advent France Biotechnology is a French Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward. Advent co-founded the company with the research team.
Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA.
Tridek One is aiming to develop immunomodulatory compounds targeting the CD31 pathway.Tridek One is a biopharmaceutical company pioneering a new class of therapeutics that can reestablish a physiological process of regulation of the immune response on activated cells.